Volloch V, Rits-Volloch S
Genes (Basel). 2025; 16(1.
PMID: 39858593
PMC: 11764795.
DOI: 10.3390/genes16010046.
Volloch V, Rits-Volloch S
Int J Mol Sci. 2024; 25(18).
PMID: 39337400
PMC: 11432332.
DOI: 10.3390/ijms25189913.
Volloch V, Rits-Volloch S
Int J Mol Sci. 2024; 25(11).
PMID: 38892224
PMC: 11172602.
DOI: 10.3390/ijms25116036.
Volloch V, Rits-Volloch S
Int J Mol Sci. 2024; 25(5).
PMID: 38474228
PMC: 10932000.
DOI: 10.3390/ijms25052981.
Hill J, Shalaby K, Bihaqi S, Alansi B, Barlock B, Parang K
Int J Mol Sci. 2023; 24(20).
PMID: 37894896
PMC: 10607430.
DOI: 10.3390/ijms242015216.
The Amyloid Cascade Hypothesis 2.0 for Alzheimer's Disease and Aging-Associated Cognitive Decline: From Molecular Basis to Effective Therapy.
Volloch V, Rits-Volloch S
Int J Mol Sci. 2023; 24(15).
PMID: 37569624
PMC: 10419172.
DOI: 10.3390/ijms241512246.
Modulation of hepatic amyloid precursor protein and lipoprotein receptor-related protein 1 by chronic alcohol intake: Potential link between liver steatosis and amyloid-β.
Garcia J, Chang R, Steinberg R, Arce A, Yang J, Van Der Eb P
Front Physiol. 2022; 13:930402.
PMID: 36187787
PMC: 9520570.
DOI: 10.3389/fphys.2022.930402.
CRISPR base editing of cis-regulatory elements enables the perturbation of neurodegeneration-linked genes.
Lim C, McCallister T, Saporito-Magrina C, McPheron G, Krishnan R, Zeballos C M
Mol Ther. 2022; 30(12):3619-3631.
PMID: 35965414
PMC: 9734028.
DOI: 10.1016/j.ymthe.2022.08.008.
Gene Therapy Approach with an Emphasis on Growth Factors: Theoretical and Clinical Outcomes in Neurodegenerative Diseases.
Parambi D, Alharbi K, Kumar R, Harilal S, El-Saber Batiha G, Cruz-Martins N
Mol Neurobiol. 2021; 59(1):191-233.
PMID: 34655056
PMC: 8518903.
DOI: 10.1007/s12035-021-02555-y.
News from Mars: Two-Tier Paradox, Intracellular PCR, Chimeric Junction Shift, Dark Matter mRNA and Other Remarkable Features of Mammalian RNA-Dependent mRNA Amplification. Implications for Alzheimer's Disease, RNA-Based Vaccines and mRNA Therapeutics.
Volloch V, Rits-Volloch S
Ann Integr Mol Med. 2021; 2:131-173.
PMID: 33942036
PMC: 8088752.
DOI: 10.33597/aimm.02-1009.
Alzheimer's Disease Prevention and Treatment: Case for Optimism.
Volloch V, Olsen B, Rits S
Ann Integr Mol Med. 2020; 2(1):115-130.
PMID: 33043322
PMC: 7546530.
DOI: 10.33597/aimm.02-1008.
Alzheimer's Disease is Driven by Intraneuronally Retained Beta-Amyloid Produced in the AD-Specific, βAPP-Independent Pathway: Current Perspective and Experimental Models for Tomorrow.
Volloch V, Olsen B, Rits S
Ann Integr Mol Med. 2020; 2(1):90-114.
PMID: 32617536
PMC: 7331974.
DOI: 10.33597/aimm.02-1007.
Special Issue: Alzheimer's disease.
Nguyen K
AIMS Neurosci. 2020; 5(1):74-80.
PMID: 32341952
PMC: 7181894.
DOI: 10.3934/Neuroscience.2018.1.74.
AD "Statin": Alzheimer's Disorder is a "Fast" Disease Preventable by Therapeutic Intervention Initiated Even Late in Life and Reversible at the Early Stages.
Volloch V, Olsen B, Rits S
Ann Integr Mol Med. 2020; 2(1):75-89.
PMID: 32201863
PMC: 7083596.
DOI: 10.33597/aimm.02-1006.
Precursor-Independent Overproduction of Beta-Amyloid in AD: Mitochondrial Dysfunction as Possible Initiator of Asymmetric RNA-Dependent βAPP mRNA Amplification. An Engine that Drives Alzheimer's Disease.
Volloch V, Olsen B, Rits S
Ann Integr Mol Med. 2019; 1(1):61-74.
PMID: 31858090
PMC: 6922309.
Results of Beta Secretase-Inhibitor Clinical Trials Support Amyloid Precursor Protein-Independent Generation of Beta Amyloid in Sporadic Alzheimer's Disease.
Volloch V, Rits S
Med Sci (Basel). 2018; 6(2).
PMID: 29865246
PMC: 6024788.
DOI: 10.3390/medsci6020045.
Ultra-Early Phase pathologies of Alzheimer's disease and other neurodegenerative diseases.
Okazawa H
Proc Jpn Acad Ser B Phys Biol Sci. 2017; 93(6):361-377.
PMID: 28603208
PMC: 5709537.
DOI: 10.2183/pjab.93.022.
Amyloid precursor protein and amyloid precursor-like protein 2 in cancer.
Pandey P, Sliker B, Peters H, Tuli A, Herskovitz J, Smits K
Oncotarget. 2016; 7(15):19430-44.
PMID: 26840089
PMC: 4991393.
DOI: 10.18632/oncotarget.7103.
Tolfenamic acid reduces tau and CDK5 levels: implications for dementia and tauopathies.
Adwan L, Subaiea G, Basha R, Zawia N
J Neurochem. 2014; 133(2):266-72.
PMID: 25279694
PMC: 4385008.
DOI: 10.1111/jnc.12960.
Insights into the physiological function of the β-amyloid precursor protein: beyond Alzheimer's disease.
Dawkins E, Small D
J Neurochem. 2014; 129(5):756-69.
PMID: 24517464
PMC: 4314671.
DOI: 10.1111/jnc.12675.